CHELMSFORD, Mass., Nov. 22, 2019 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq:BRKS) announced today that company
management will participate in two upcoming investor
conferences:
- Credit Suisse 23rd Annual Technology Conference in
Scottsdale, AZ on December 3, 2019 with a webcast beginning at
2:20 p.m. MST (4:20 p.m. EST).
- Evercore ISI 2nd Annual HealthCONx Conference in Boston, MA on December
5, 2019 with a webcast beginning at 9:30 a.m. EST.
The live audio webcasts can be accessed through the Investor
Relations page of the Brooks Automation website at www.brooks.com.
A replay of the presentations will be available following the
events.
About Brooks Automation
Brooks is a leading
provider of life science and semiconductor manufacturing automation
solutions worldwide. The Company applies its automation and
cryogenics expertise to provide a full suite of reliable cold-chain
sample management solutions across life sciences in areas such as
drug development, clinical research and advanced cell
therapies. Brooks recently added global capability for gene
sequencing and gene synthesis services through its strategic
acquisition of GENEWIZ, expanding its sample-based services
offerings. With over 40 years as a partner to the
semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision robotics, integrated automation systems
and services. Brooks is headquartered in Chelmsford, MA, with operations in
North America, Europe and Asia. For more information, visit
www.brooks.com.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
John Mills
Senior Managing Director
ICR, LLC
646.277.1254
John.mills@icrinc.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-to-participate-in-upcoming-investor-conferences-300964097.html
SOURCE Brooks Automation